Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis
Clinical trial NCT01061723 · COMPLETED
Trial details
- NCT number
- NCT01061723
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-06-01
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.